z-logo
Premium
Amphiphilic A x B y mikto‐arm star copolymers with PLMA and POEGMA arms: Self‐assembly and drug encapsulation
Author(s) -
Vlassi Eleni,
Papagiannopoulos Aristeidis,
Pispas Stergios
Publication year - 2021
Publication title -
journal of polymer science
Language(s) - English
Resource type - Journals
eISSN - 2642-4169
pISSN - 2642-4150
DOI - 10.1002/pol.20210082
Subject(s) - amphiphile , copolymer , ethylene glycol , hydrophobic effect , chemistry , polymer chemistry , methacrylate , micelle , aqueous solution , self assembly , chemical engineering , organic chemistry , polymer , engineering
We report on the synthesis and self‐assembly of amphiphilic mikto‐arm star copolymers of the A x B y type with mixed arms of poly(lauryl methacrylate) and poly(oligo ethylene glycol methacrylate). Two star copolymers with different hydrophobic‐to‐hydrophilic ratios are prepared in order to study their self‐assembly in aqueous media. Both stars organize in structures with dimensions in the nanoscale. The star with the lower hydrophobic content forms aggregates of lower size and molar mass and it has a higher critical aggregation concentration. The synthesized mikto‐arm stars are able to encapsulate curcumin (CUR) and preserve its fluorescence properties while their self‐organization is affected by the incorporation of the hydrophobic drug compound. Interestingly, the more hydrophilic star is more strongly affected by the presence of CUR in terms of aggregate size and mass. In phosphate buffered saline (PBS) and fetal bovine serum‐PBS solutions the star with higher hydrophobic content appears to better preserve its monomodal size distribution in comparison to the star with lower hydrophobic content either with or without encapsulated CUR. This work opens possibilities for using the new star copolymers in the solubilization of hydrophobic compounds and the delivery of hydrophobic drugs for pharmaceutical and bioimaging applications.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here